Business Context and Reporting Period
Company: CorVel Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: December 31, 2008
Business Overview: CorVel is an independent nationwide provider of medical cost containment and managed care services, primarily for workers' compensation and auto policies. The company operates in a single reportable segment: managed care, offering network solutions (fee auditing, PPO services) and patient management services (utilization review, case management).
Key Financial Metrics
| Metric | Three Months Ended Dec 31, 2008 | Nine Months Ended Dec 31, 2008 |
|---|---|---|
| Revenues | $76.96 million | $233.02 million |
| Cost of Revenues | $59.30 million | $176.56 million |
| Gross Profit | $17.66 million | $56.45 million |
| Gross Margin | 22.9% | 24.2% |
| Net Income | $4.50 million | $15.04 million |
| Diluted EPS | $0.34 | $1.09 |
| Cash and Equivalents | $12.14 million (Dec 31, 2008) | N/A |
| Operating Cash Flow (9mo) | N/A | $23.61 million |
| Total Debt | $0 | $0 |
Material Changes vs. Prior Period
- Revenue: Increased 0.4% ($0.3M) for the quarter and 3.8% ($8.5M) for the nine months compared to the prior year periods. Growth was driven by network solutions and the prior-year acquisition of Schaffer, offset by a softer claims environment and declining manufacturing employment.
- Profitability: Net income decreased 24.8% ($1.5M) for the quarter and 12.5% ($2.1M) for the nine months. Gross margins compressed from 26.6% to 22.9% (quarterly) due to a mix shift toward lower-margin services and rising labor costs.
- Expenses: Cost of revenues increased 5.4% (quarterly) due to higher salaries and pharmacy service costs. General and administrative expenses decreased 2.7% (quarterly) due to reduced system costs, though legal expenses rose.
- Liquidity: Cash and cash equivalents decreased from $17.9 million (March 31, 2008) to $12.1 million (December 31, 2008), primarily driven by significant share repurchases.
Outlook, Risks, and Unusual Items
- Share Repurchases: The company aggressively repurchased stock, spending $22.2 million to buy back 922,919 shares during the nine months ended December 31, 2008. The repurchase program authorization was expanded to 13.15 million shares in September 2008.
- Acquisitions: No new acquisitions occurred in the period. The company paid $1.8 million in earn-out obligations related to the 2007 Schaffer acquisition.
- Legal Proceedings: A putative class action lawsuit filed in 2005 by Kathleen Roche, D.C., regarding PPO network steering and software bias remains pending. The Illinois Supreme Court denied the company's appeal in September 2008. The company cannot estimate the potential loss.
- Internal Controls: Management disclosed that disclosure controls and procedures were not effective due to material weaknesses in accounts payable and financial close/reporting processes identified in the prior fiscal year. Remediation is ongoing via new software implementation.
- Market Risks: Management cites a challenging environment due to declining manufacturing jobs, price competition, and potential legislative changes in workers' compensation laws that could reduce demand for services.
Investor Verification Checklist
- Margin Compression: Verify the sustainability of the 22.9% gross margin given the shift to lower-margin services and rising labor costs.
- Legal Exposure: Monitor the status of the Roche class action lawsuit, as an unfavorable outcome could materially impact financial results.
- Internal Controls: Track the progress of remediation efforts for the material weaknesses in accounts payable and financial reporting to ensure future compliance with Sarbanes-Oxley.
- Cash Flow vs. Buybacks: Assess whether the $12.1 million cash balance is sufficient to fund operations and continued share repurchases without external financing, given the decline in operating cash flow.
- Revenue Drivers: Confirm if the decline in manufacturing employment and workplace injuries will continue to suppress bill volume and revenue growth.